Today’s episode is about the science of slowing down the aging process … and why one biotech company has found some success with dogs. Last November, the New York Times reported that a company called Loyal had reached a milestone in the development of safe life extension drugs for our pets. This drug, which is called LOY-1, works to slow the aging process in large breeds. But Loyal's work holds major promise for helping all dogs live longer. It could even crack open some of the mysteries of mammalian aging, which could lead to discoveries that extend the lives of humans.

Today's guest is the CEO and founder of Loyal, Celine Halioua. We talk about her experience as a female biotech founder, the weird economics of pharma, the ethics of life extension, the science of why big dogs die young, her theories for how to slow down the aging process in dogs big and small, and the possibility spillover benefits for humans who would like a few more years with their family and friends.

If you have questions, observations, or ideas for future episodes, email us at [email protected].

Host: Derek Thompson

Guest: Celine Halioua

Producer: Devon Baroldi

Learn more about your ad choices. Visit podcastchoices.com/adchoices